Saturday, March 29, 2025

Suki and Amwell Partner to Expand Access to AI Solutions that Empower Clinicians and Patients

Related stories

RoboSense and LionsBot Announce Strategic Partnership

RoboSense, a pioneering AI-driven robotics technology company, and LionsBot,...

Corning Unveils GlassWorks AI Solutions to Support AI Data Center Infrastructure

Corning Incorporated has introduced GlassWorks AI Solutions, a comprehensive...

Workato Acquires DeepConverse to Enhance Generative AI-Powered Automation

Workato, a leader in enterprise automation, has announced the...

Kyndryl Expands Google Cloud Partnership to Drive Mainframe Modernization with Generative AI

Kyndryl, a global IT infrastructure services leader, has announced...
spot_imgspot_img

Two leading players in the health tech space have joined forces to integrate Suki’s AI Assistant to providers using Amwell’s Converge Platform

Suki, the leader in voice artificial intelligence (AI) technology for healthcare, and Amwell, a leading hybrid care delivery enablement platform, partner to bring the AI-powered Suki Assistant to Amwell’s Converge telehealth platform powering the digital care of more than 55 health plans representing more than 90 million people. This partnership showcases Amwell’s leadership in leveraging cutting-edge technology to enhance outcomes for all stakeholders, from providers to payers.

Amwell connects and enables providers across 2,000+ hospitals such as Cleveland Clinic, Northwell Health, and Intermountain Healthcare, to deliver greater access to more affordable, higher-quality care. Converge revolutionizes healthcare delivery by offering a streamlined patient experience without needing app downloads or waiting rooms, and ensuring services are tailored to individual needs with real-time eligibility checks. It enhances efficiency by intelligently matching consumers with providers, integrating seamlessly into existing workflows, and maintaining network integrity through referral management.

Also Read: Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050

The platform excels in improving access and outcomes, featuring chat-based support, mental health programs, and in-visit enrollment for clinical programs. With impressive metrics like a 95 percent visit success rate, 99.9 percent uptime, and three times faster visit connections than its legacy system, Converge demonstrates a commitment to high-quality, efficient, and patient-centered care.

Suki is a voice-enabled digital assistant for healthcare that leverages advanced AI to streamline administrative tasks. It helps clinicians complete notes 72 percent faster on average, supports other tasks including coding and dictation, and generates incremental revenue for organizations, delivering a 9X ROI in year one. It is available directly within the Converge platform, fitting seamlessly into the workflows of Amwell providers.

“Implementing AI voice technology into Amwell’s hybrid care platform not only helps their providers avoid the burdensome documentation work that leads to significant burnout across the healthcare industry, it also helps providers be more engaged during appointments,” said Punit Soni, CEO and founder of Suki. “We’re thrilled to partner with Amwell to power the AI voice experience of Converge so clinicians can focus on what matters most: their patients.”

SOURCE: PRNewswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img